Free Trial

International Biotechnology (LON:IBT) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

International Biotechnology logo with Financial Services background

Key Points

  • International Biotechnology (LON:IBT) shares have recently surpassed their 200-day moving average of GBX 618.80, with the stock trading up to GBX 750.
  • The company has a market capitalization of £250.74 million and a notably high price-to-earnings ratio of 1,539.10.
  • International Biotechnology aims for long-term capital growth by investing in a diversified portfolio of biotechnology and life sciences companies with strong growth prospects.
  • MarketBeat previews top five stocks to own in November.

International Biotechnology (LON:IBT - Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 618.80 ($8.32) and traded as high as GBX 750 ($10.09). International Biotechnology shares last traded at GBX 744 ($10.01), with a volume of 406,400 shares.

International Biotechnology Price Performance

The firm's 50-day simple moving average is GBX 670.36 and its two-hundred day simple moving average is GBX 618.80. The company has a market capitalization of £250.74 million, a price-to-earnings ratio of 1,539.10 and a beta of 0.21.

International Biotechnology Company Profile

(Get Free Report)

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in International Biotechnology Right Now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.